Rabisin
Rabisin
Authorised
- Rabies virus, strain G52, Inactivated
Product identification
Medicine name:
Rabisin
Active substance:
- Rabies virus, strain G52, Inactivated
Target species:
-
Sheep
-
Dog
-
Mustelids
-
Cattle
-
Cat
-
Horse
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain G52, Inactivated1.00international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Sheep
-
Meat and offal0day
-
Milk0day
-
-
Dog
-
Mustelids
-
Cattle
-
Milk0day
-
Meat and offal0day
-
-
Cat
-
Horse
-
Milk0day
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Cattle
-
Milk0day
-
Meat and offal0day
-
-
Sheep
-
Meat and offal0day
-
Milk0day
-
-
Dog
-
Mustelids
-
Horse
-
Milk0day
-
Meat and offal0day
-
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 94a/84
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 31/07/2024
How useful was this page?: